ArticleBMC public health2020

Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.

André B Kind et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.